Hear from our Fanatical Customers
Hear from some of our delighted customers about how LabFellows has improved their LabOps, and their business. Our LabOps automation platform is designed to put the lab operators’ experience first. Hear first-hand how our customers are using LabFellows to run the lab of the future.
Customer Success Stories
From Small Teams to Public Companies
"Chemical analysis was a major bottleneck in our R&D program. We are a startup with a limited budget for large applications or devices, and accessing this capacity via LabFellows provided a huge value to us."
Scientist at major plant-based meat company.
Dr. Robert O’Brien
"LabFellows provides more efficiency for researchers."
Senior VP & Chief Policy Officer, BIOCOM
Jimmy Jackson
"LabFellows integrates and enhances our experience from the requisitioner all the way to the receiving and inventory systems. Letting us focus on accelerating our modern universal antivenom to market."
Founder & Chief Executive Officer, Venomyx (IndieBio Cohort 04)
Dan T. Dempsey
"The platform has been really excellent. We're spending more time on our research, and less managing spreadsheets and vendors."
Chief Operating Officer, MicroSynbiotiX (RebelBio Cohort 03)
Antonio Lamb
"LabFellows is a strategic partner. From our lab setup, all the way to maintaining EH&S compliance has been completely turnkey, and allowed us to remain fully operational throughout COVID-19 pandemic."
Co-Founder & Chief Science Officer, Elevate Technologies PR
Wayne Green
"LabFellows is one of our most exciting investments because they have the potential to become the operating system of the life sciences lab space. The company is adding new layers of efficiency and functionality into a large niche market that almost nobody else is focusing on, and what makes them so exciting is that they add value to almost every player in the life sciences ecosystem."
Managing Director, Right Side Capital Management.
David Lambert
"Serendipitous executive connections, a high-value partnership with a leading Indian biopharmaceutical manufacturing facility, and access to LabFellows Remote Lab Management solution made the unconventional path to our $65M IPO in 19 months possible"
Chief Scientific Officer, Equillium, Inc.
Stephen Connelly PhD, MBA
Have Questions? We can help! and below
Let’s start the conversation. Tell us a bit about yourself, and we’ll get back to you soon.